STOCK ALARM
PRO
SA
PRO
Menu
Explore
News
Screener
Alerts
⌘K
⌘J
Pro
Sign In
Free Account
Themes
RedHill Biopharma Ltd.
RDHL
NASDAQ
Loading
Overview
Intelligence
Charts
News
Fundamentals
Key Metrics
Financials
Growth
Insiders
Analysis
More
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Loading chart...
As of
2024
• vs 2023
Annual
Quarterly
Core Metrics
Market Cap
$15.30M
-19.1%
P/E Ratio
-1.85
-334.0%
P/S Ratio
1.90
-34.3%
ROE
176.55%
-84.7%
ROIC
420.64%
+74.5%
FCF Yield
-61.27%
+67.7%
Debt/Equity
-0.08
-113.4%
Current Ratio
0.54
-36.1%
Interest Coverage
-265.69x
-871.9%
Per Share
Revenue/Share
$3.26
-74.1%
Net Income/Share
$-3.35
-107.3%
Operating CF/Share
$-3.80
+94.5%
Free CF/Share
$-3.81
+94.5%
Cash/Share
$1.87
-84.7%
Book Value/Share
$-1.90
-147.6%
Tangible Book/Share
$-4.15
+38.7%
Equity/Share
$-1.90
-147.6%
Interest Debt/Share
$0.17
-94.4%
Valuation
Market Cap
$15.30M
-19.1%
Enterprise Value
$11.04M
-23.9%
P/E Ratio
-1.85
-334.0%
P/S Ratio
1.90
-34.3%
P/OCF Ratio
-1.63
-209.3%
P/FCF Ratio
-1.63
-209.1%
P/B Ratio
-3.27
-135.7%
P/TB Ratio
-3.27
-135.7%
EV/Sales
1.37
-38.2%
EV/EBITDA
-1.45
-363.1%
Profitability
Earnings Yield
-54.02%
-142.7%
FCF Yield
-61.27%
+67.7%
ROE
176.55%
-84.7%
ROIC
420.64%
+74.5%
Return on Tangible Assets
-66.17%
-148.3%
Capital Allocation
CapEx/OCF
-0.10%
-212.8%
CapEx/Revenue
0.11%
-33.6%
CapEx/Depreciation
0.01
+163.0%
SBC/Revenue
8.27%
-67.2%
Balance Sheet
Debt/Equity
-0.08
-113.4%
Debt/Assets
0.02
-61.2%
Net Debt/EBITDA
0.56
+435.3%
Current Ratio
0.54
-36.1%
Interest Coverage
-265.69x
-871.9%
Income Quality
1.13
+175.7%
Efficiency
Days Sales Outstanding
162 days
-11.9%
Days Payables Outstanding
899 days
+159.9%
Days Inventory
417 days
-9.9%
Receivables Turnover
2.26x
+13.5%
Payables Turnover
0.41x
-61.5%
Inventory Turnover
0.87x
+10.9%
Special Valuations
Graham Number
--
Graham Net-Net
$-5.52
+71.3%